Commission

European Commission approves first drug for prurigo nodularis

European Commission approves first drug for prurigo nodularis

tricked®the first and only targeted medicine for prurigo nodularis has been approved by the EC for adults with moderate to severe disease. The European Commission (EC) has extended the marketing authorization for Dupixent® (dupilumab) in the European Union (EU), to treat adults with moderate to severe nodular prurigo (PN) who are candidates for systemic therapy, …

European Commission approves first drug for prurigo nodularis Read More »

Iris Telehealth Achieves Joint Commission Behavioral Healthcare Recertification

Iris Telehealth Achieves Joint Commission Behavioral Healthcare Recertification

The designation recognizes the company’s commitment to providing high quality telepsychiatry services AUSTIN, TX, December 8, 2022 /PRNewswire/ — Iris Telehealth, a leading provider of telepsychiatry services to health systems and community health centers across the United States, today announced that it has been recertified with the Commission’s Gold Seal of Approval® co-ed for behavioral …

Iris Telehealth Achieves Joint Commission Behavioral Healthcare Recertification Read More »